Pfizer loses blockbuster drug patent fight in UK Supreme Court


Pfizer lost the final round in a long-running patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica. FILE PHOTO: A logo of American pharmaceutical corporation Pfizer Inc., is pictured in Toluca, Mexico October 1, 2018.



from Biotech News